{"id":"https://openalex.org/W24969260","doi":"https://doi.org/10.1182/blood.v122.21.1133.1133","title":"Four-Factor Prothrombin Complex Concentrate (4-PCC) Effectively Reverses Edoxaban Induced Bleeding In a Rabbit Model Of Acute Injury","display_name":"Four-Factor Prothrombin Complex Concentrate (4-PCC) Effectively Reverses Edoxaban Induced Bleeding In a Rabbit Model Of Acute Injury","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W24969260","doi":"https://doi.org/10.1182/blood.v122.21.1133.1133","mag":"24969260"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1133.1133","doi":"https://doi.org/10.1182/blood.v122.21.1133.1133","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1133.1133","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085463298","display_name":"Eva Herzog","orcid":"https://orcid.org/0000-0001-8670-7688","observed_orcids":["https://orcid.org/0000-0001-8670-7688"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Eva Herzog","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030239563","display_name":"Franz Kaspereit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Franz Kaspereit","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084604128","display_name":"Wilfried Krege","orcid":"https://orcid.org/0000-0001-6636-9191","observed_orcids":["https://orcid.org/0000-0001-6636-9191"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wilfried Krege","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058969386","display_name":"Ingo Pragst","orcid":"https://orcid.org/0000-0002-1259-5422","observed_orcids":["https://orcid.org/0000-0002-1259-5422"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ingo Pragst","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072163593","display_name":"Yoshiyuki MORISHIMA","orcid":"https://orcid.org/0000-0002-5062-1134","observed_orcids":["https://orcid.org/0000-0002-5062-1134"]},"institutions":[{"id":"https://openalex.org/I4210104626","display_name":"Daiichi-Sankyo (Japan)","ror":"https://ror.org/027y26122","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210104626"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshiyuki Morishima","raw_affiliation_strings":["Biological Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210104626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078530248","display_name":"Stefan Schulte","orcid":"https://orcid.org/0000-0001-6286-6334","observed_orcids":["https://orcid.org/0000-0001-6286-6334"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Schulte","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019708506","display_name":"Gerhard Dickneite","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerhard Dickneite","raw_affiliation_strings":["Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Research & Development, CSL Behring GmbH, Marburg, Germany,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030239563","https://openalex.org/A5058969386","https://openalex.org/A5072163593","https://openalex.org/A5084604128","https://openalex.org/A5085463298"],"corresponding_institution_ids":["https://openalex.org/I4210104626"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6962,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.75698163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":97},"biblio":{"volume":"122","issue":"21","first_page":"1133","last_page":"1133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.45579999685287476,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.45579999685287476,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.451200008392334,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.055799998342990875,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/four-factor-prothrombin-complex-concentrate","display_name":"four-factor prothrombin complex concentrate","score":0.9589999914169312},{"id":"https://openalex.org/keywords/edoxaban","display_name":"edoxaban","score":0.9169999957084656},{"id":"https://openalex.org/keywords/anticoagulation-reversal","display_name":"anticoagulant reversal","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hemorrhage","display_name":"hemorrhage","score":0.5479999780654907},{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.8220000267028809},{"id":"https://openalex.org/keywords/direct-oral-anticoagulants","display_name":"direct oral anticoagulants","score":0.8980000019073486},{"id":"https://openalex.org/keywords/kidney-injury","display_name":"kidney injury","score":0.5680000185966492},{"id":"https://openalex.org/keywords/rabbit-model","display_name":"rabbit model","score":0.7059999704360962},{"id":"https://openalex.org/keywords/thrombin-generation","display_name":"thrombin generation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/endogenous-thrombin-potential","display_name":"endogenous thrombin potential","score":0.9829999804496765},{"id":"https://openalex.org/keywords/prothrombin-time","display_name":"prothrombin time","score":0.8970000147819519},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9010000228881836},{"id":"https://openalex.org/keywords/whole-blood-clotting-time","display_name":"whole blood clotting time","score":0.8330000042915344},{"id":"https://openalex.org/keywords/bleeding-prevention","display_name":"bleeding prevention","score":0.6179999709129333},{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.7789999842643738}],"concepts":[{"id":"https://openalex.org/C2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","level":5,"score":0.9807499647140503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9353752136230469},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.532371461391449},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.5107288360595703},{"id":"https://openalex.org/C2778261982","wikidata":"https://www.wikidata.org/wiki/Q1755136","display_name":"Partial thromboplastin time","level":3,"score":0.5043498277664185},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.49686744809150696},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.4901038110256195},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.4620600938796997},{"id":"https://openalex.org/C144594695","wikidata":"https://www.wikidata.org/wiki/Q6153218","display_name":"Thromboplastin","level":3,"score":0.4532233476638794},{"id":"https://openalex.org/C2780434524","wikidata":"https://www.wikidata.org/wiki/Q1144385","display_name":"Prothrombin time","level":2,"score":0.4400276839733124},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36341652274131775},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3062836229801178},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.2328168749809265}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1133.1133","doi":"https://doi.org/10.1182/blood.v122.21.1133.1133","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1133.1133","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2047342431","https://openalex.org/W2098215452","https://openalex.org/W1965691938","https://openalex.org/W2588075790","https://openalex.org/W87827122","https://openalex.org/W2121796495","https://openalex.org/W2783205823","https://openalex.org/W1967206272","https://openalex.org/W2003847848","https://openalex.org/W1807747759"],"abstract_inverted_index":{"Abstract":[0],"This":[1],"study":[2,149,293],"was":[3,150],"designed":[4,152],"to":[5,111,118,134,153,160,190,200,246,269,281],"determine":[6],"whether":[7],"the":[8,47,68,78,94,120,140,143,156,162,215,233,251,284],"four-factor":[9],"Prothrombin":[10],"Complex":[11],"Concentrate":[12],"(4-PCC)":[13],"Beriplex\u00ae":[14],"P/N":[15],"(Kcentra\u2122)":[16],"can":[17],"effectively":[18,314],"reverse":[19,119,161],"bleeding":[20,194,263,325],"following":[21,195],"edoxaban":[22,38,166,186,211,261,302,316],"administration":[23,249],"in":[24,44,53,63,72,105,138,169,214,256,319],"a":[25,180,257],"rabbit":[26,171],"kidney":[27,197],"injury":[28,198],"model.":[29],"The":[30,85,147,295],"oral":[31,145],"direct":[32],"and":[33,59,77,80,129,192,225,231,244,271,308],"selective":[34],"factor":[35],"Xa":[36],"inhibitor":[37],"(Daiichi":[39],"Sankyo)":[40],"is":[41,60,93],"currently":[42],"available":[43,90],"Japan":[45],"for":[46,67],"prophylaxis":[48],"of":[49,70,83,88,96,100,122,142,158,165,173,185,205,207,217,250,260,287,323],"venous":[50],"thromboembolism":[51],"(VTE)":[52],"patients":[54,73,106],"undergoing":[55,61],"major":[56],"orthopedic":[57],"surgery":[58],"investigation":[62],"phase":[64],"III":[65],"trials":[66],"prevention":[69],"stroke":[71],"with":[74,179,299],"atrial":[75],"fibrillation":[76],"treatment":[79,109,212,313],"secondary":[81],"prevetion":[82],"VTE.":[84],"primary":[86],"complication":[87],"any":[89],"anticoagulant":[91,163],"therapy":[92],"risk":[95],"bleeding.":[97,113,175],"Rapid":[98],"reversal":[99,259,304],"anticoagulation":[101,303],"may":[102],"be":[103,135],"necessary":[104],"requiring":[107],"emergency":[108],"due":[110],"uncontrolled":[112],"PCCs":[114],"are":[115],"frequently":[116],"used":[117],"effect":[121],"vitamin":[123],"K":[124],"antagonists":[125],"such":[126],"as":[127,264],"warfarin":[128],"have":[130],"also":[131],"been":[132],"suggested":[133],"potentially":[136],"effective":[137],"reversing":[139],"effects":[141],"new":[144],"anticoagulants.":[146],"present":[148],"therefore":[151],"further":[154],"investigate":[155],"ability":[157],"4-PCC":[159,252,285,300,312],"action":[164],"using":[167],"an":[168,320],"vivo":[170],"model":[172,322],"acute":[174,324],"Animals":[176],"were":[177],"treated":[178],"high":[181],"intravenous":[182],"bolus":[183],"dose":[184,286,329],"(1200":[187],"\u00b5g/kg)":[188],"leading":[189],"increased":[191],"prolonged":[193],"standardized":[196],"compared":[199,280],"vehicle":[201],"administration.":[202],"Parallel":[203],"monitoring":[204],"biomarkers":[206,296],"haemostasis":[208,270],"showed":[209],"that":[210],"resulted":[213,255],"prolongation":[216],"prothrombin":[218],"time":[219,229,245,268],"(PT),":[220],"activated":[221],"partial":[222],"thromboplastin":[223],"time,":[224],"whole":[226],"blood":[227,273],"clotting":[228],"(WBCT),":[230],"affected":[232],"thrombin":[234,237,240],"generation":[235],"parameters":[236,276],"peak,":[238],"endogenous":[239],"potential":[241],"(ETP),":[242],"lagtime":[243],"peak.":[247],"Subsequent":[248],"(25-75":[253],"IU/kg)":[254],"dose-dependent":[258],"induced":[262,317],"indicated":[265],"by":[266],"reduced":[267],"total":[272],"loss.":[274],"Both":[275],"achieved":[277],"statistical":[278],"significance":[279],"placebo":[282],"at":[283,326],"50":[288],"IU/kg":[289],"under":[290],"fully":[291],"blinded":[292],"conditions.":[294],"correlating":[297],"best":[298],"mediated":[301],"included":[305],"PT,":[306],"WBCT":[307],"ETP.":[309],"In":[310],"summary,":[311],"decreased":[315],"hemorrhage":[318],"animal":[321],"clinically":[327],"relevant":[328],"levels.":[330],"Disclosures:":[331],"Herzog:":[332],"CSL":[333],"Behring":[334,338,342,346,353,357],"GmbH:":[335,339,343,347,354,358],"Employment.":[336,340,344,348,351,355,359],"Kaspereit:CSL":[337],"Krege:CSL":[341],"Pragst:CSL":[345],"Morishima:Daiichi":[349],"Sankyo:":[350],"Schulte:CSL":[352],"Dickneite:CSL":[356]},"counts_by_year":[{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}